Healthcare

Singular Health Group Ltd (ASX:SHG) shares moved 4.55% higher to AUD 0.23 during the morning session on 22 April 2026, following the release of an operational update tied to its United States enterprise agreement. Despite the stock remaining unchanged over the past year, the …

Cochlear (ASX:COH) shares fell AUD 61.929, or 36.876%, to AUD 106.010 on 22 April 2026, on volume of 797,658 shares with a bid-offer spread of AUD 106.000 to AUD 106.140 and market capitalisation of AUD 10.98 billion. The 36.9% single-session decline is an extraordinary …

South32 (ASX:S32) shares eased AUD 0.030, or 0.680%, to AUD 4.380 during morning trading on 22 April 2026, on volume of 4,310,470 shares with a bid-offer spread of AUD 4.370 to AUD 4.380 and market capitalisation of AUD 19.78 billion. The minor session decline …

The BCC expansion is strategically important because BCCs account for approximately 80% of all skin cancers, dramatically increasing the addressable market and commercial optionality for INV043. BCCs are also difficult to grow in animal models, meaning human clinical data becomes particularly valuable for advancing …

ImpediMed Ltd (ASX:IPD) ended Monday's session at $0.014, a single-day decline of 12.50% per the ASX top losers data for 20 April 2026.

Nexalis Therapeutics Ltd (ASX:NX1) recorded a 4.35% gain on 20 April 2026, as investors responded to a key clinical milestone in its development pipeline. The company announced that the first patient has been screened in its Phase 2 trial for IRX-211, a therapy targeting …

Nexalis Therapeutics Ltd (ASX:NX1) recorded a 4.35% gain on 20 April 2026, as investors responded to a key clinical milestone in its development pipeline. The company announced that the first patient has been screened in its Phase 2 trial for IRX-211, a therapy targeting …